ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P ASX 200
7,997.10
0.00%
S&P ASX All Technology
3,441.80
0.00%
Brent Oil
64.615
-2.14%
US Dollar vs AUD
1.55461
-0.80%
Bitcoin
94,656.57
0.97%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. WhiteHorse Finance Inc (WHF) Share Price

WhiteHorse Finance Inc

WhiteHorse Finance Inc (WHF)

Whitefield Industrials Ltd
9.81
0.01
(0.10%)
At close: 29 April 6:00AM
Delayed by 15 minutes
9.84
0.03
( 0.31% )
After Hours: 6:00AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
9.84
Bid
9.81
Offer
9.84
Volume
48,660
9.74 Day's Range 9.9212
8.435 52 Week Range 13.44
Market Cap
228.712M
Previous Close
9.80
Open
9.82
Last Trade
1
@
9.84
Last Trade Time
06:05:13
Financial Volume
US$ 478,973
VWAP
9.8433
Average Volume (3m)
94,630
Shares Outstanding
23,243,088
Dividend Yield
15.65%
PE Ratio
21.02
Earnings Per Share (EPS)
0.47
Revenue
92.82M
Net Profit
10.85M

About WhiteHorse Finance Inc

WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held, small-cap companies located in North America. Its investment objective is to generate attractive risk-adjusted returns for investors, primarily by originating senior se... WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held, small-cap companies located in North America. Its investment objective is to generate attractive risk-adjusted returns for investors, primarily by originating senior secured loans to privately held small-cap companies across a broad range of industries. Show more

Sector
Unit Inv Tr, Closed-end Mgmt
Industry
Unit Inv Tr, Closed-end Mgmt
Website
www.whitehorsefinance.com
Headquarters
Wilmington, Delaware, USA
Founded
-
WhiteHorse Finance Inc is listed in the Unit Inv Tr, Closed-end Mgmt sector of the NASDAQ with ticker WHF. The last closing price for WhiteHorse Finance was US$9.80. Over the last year, WhiteHorse Finance shares have traded in a share price range of US$ 8.435 to US$ 13.44.

WhiteHorse Finance currently has 23,243,088 shares in issue. The market capitalisation of WhiteHorse Finance is US$227.78 million. WhiteHorse Finance has a price to earnings ratio (PE ratio) of 21.02.

Ask ADVFN Intelligence (AI)

WHF Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
08 August 2024
WHF (0.10%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
08 August 2024
WHF (0.10%)

Form 8-K - Current report
Edgar (US Regulatory)
06 August 2024
WHF (0.10%)

Form 8-K - Current report
Edgar (US Regulatory)
12 July 2024
WHF (0.10%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.11.026694045179.749.959.52597619.79313154CS
40.33.144654088059.549.958.4351239329.22993958CS
12-0.65-6.1963775023810.4911.318.435946309.85710753CS
26-2.2-18.272425249212.0412.188.4359887910.13254259CS
52-3.11-24.015444015412.9513.448.4359363111.15999679CS
156-5.16-34.41515.198.4357054612.10192676CS
260-0.5-4.8355899419710.3416.727.617593812.72455503CS

WHF - Frequently Asked Questions (FAQ)

What is the current WhiteHorse Finance share price?
The current share price of WhiteHorse Finance is US$ 9.84
How many WhiteHorse Finance shares are in issue?
WhiteHorse Finance has 23,243,088 shares in issue
What is the market cap of WhiteHorse Finance?
The market capitalisation of WhiteHorse Finance is USD 227.78M
What is the 1 year trading range for WhiteHorse Finance share price?
WhiteHorse Finance has traded in the range of US$ 8.435 to US$ 13.44 during the past year
What is the PE ratio of WhiteHorse Finance?
The price to earnings ratio of WhiteHorse Finance is 21.02
What is the cash to sales ratio of WhiteHorse Finance?
The cash to sales ratio of WhiteHorse Finance is 2.46
What is the reporting currency for WhiteHorse Finance?
WhiteHorse Finance reports financial results in USD
What is the latest annual turnover for WhiteHorse Finance?
The latest annual turnover of WhiteHorse Finance is USD 92.82M
What is the latest annual profit for WhiteHorse Finance?
The latest annual profit of WhiteHorse Finance is USD 10.85M
What is the registered address of WhiteHorse Finance?
The registered address for WhiteHorse Finance is CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the WhiteHorse Finance website address?
The website address for WhiteHorse Finance is www.whitehorsefinance.com
Which industry sector does WhiteHorse Finance operate in?
WhiteHorse Finance operates in the UNIT INV TR, CLOSED-END MGMT sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PTLEPTL Ltd
US$ 1.82
(33.82%)
1.25M
WLDSWearable Devices Ltd
US$ 1.40
(16.72%)
29.41k
RNXTRenovoRx Inc
US$ 1.09
(12.14%)
1.77k
CTMXCytomX Therapeutics Inc
US$ 0.7887
(11.57%)
2.65M
VMEOVimeo Inc
US$ 5.50
(9.02%)
12.86k
FORAForian Inc
US$ 1.93
(-13.45%)
967
AVXLAnavex Life Sciences Corporation
US$ 8.3728
(-12.51%)
6.3k
PETWag Group Company
US$ 0.1448
(-12.14%)
509.93k
YMABY mAbs Therapeutics Inc
US$ 3.80
(-10.38%)
3.54k
SXTCChina SXT Pharmaceuticals Inc
US$ 2.30
(-9.80%)
15.86k
AGMHAGM Group Holdings Inc
US$ 0.121
(-7.70%)
12.76M
LGMKLogicMark Inc
US$ 0.01275
(0.39%)
3.41M
CTMXCytomX Therapeutics Inc
US$ 0.7887
(11.57%)
2.65M
LCIDLucid Group Inc
US$ 2.55
(0.99%)
2.37M
DMNDamon Inc
US$ 0.00375
(0.00%)
2.21M

Discussion

View Full Feed
imafan imafan 5 minutes ago
Eeyore has spoken! AKA professed lying short. Real News: HUUUUGE ANNOUNCEMENTS of HUUUUGE ACCOMPLISHMENTS IMMINENT!!! WHALES LURKING!!!
HHSE
StockItOut StockItOut 5 minutes ago
Another SmartyPants/Quester lie, or you have a filing to support your assertion?
XERI
fuagf fuagf 6 minutes ago
LOL Figured that comment would grab you. 🙃 Qualification to mine would be, of course, unless they had firm numbers wrapped up with more security than Fort Knox. While fully appreciating the gravity you see in the situation, and though I've read little lately, still am guessing it's better t
glenn1919 glenn1919 6 minutes ago
CTMX..............................................a/h
CTMX
dia76ca dia76ca 6 minutes ago
"Blarcamesine and Anavex 3-71 are changing the paradigm for the treatment of neurodegenerative and neurodevelopmental diseases."
Nice summary georgejjl !
Paradigm shifts are very exciting but some folks see them before others!
The rest of this year will be pivotal.
2026 s
AVXL
Lykiri Lykiri 7 minutes ago
Actually, there’s a bit of confusion here. Under the old regulation, both positive and negative recommendations were referred to the CHM for review. However, the new regulation (effective after 3 April 2025) stipulates that only applications with serious concerns are now referred to the CHM. Therefo
NWBO
I-Glow I-Glow 7 minutes ago
And the Hindenburg report.- https://hindenburgresearch.com/mullen/.

Plus, TenKay was all over the preferred shares and the financials.

IG
MULN
boi568 boi568 8 minutes ago
Even if an ADL "odds ratio" claim could normally be considered disqualifying in lieu of a comparison of the means, it just seems to me irrelevant to the EMA here, since ADL itself is a not ready for prime time EMA endpoint in an early AD trial.
AVXL
dennisdave dennisdave 8 minutes ago
I agree with your points . However there were medicines last year which got approved by MHRA but NICE decided not to get them covered by NHS same day or so. Those companies would have been in discussions with NICE before MHRA approval . So not really sure it is absolutely comforting Ok interesting
NWBO
hedge_fun hedge_fun 8 minutes ago
That’s what I said, you’re smarter than……

the markets.

In your opinion of course!
TSLA
WarMachine WarMachine 9 minutes ago
I couldn't imagine making such a fool of myself every day on a public forum.
You don't need to imagine it. LOL
they are beyond clueless about what's really happening here
Explain, IN DETAIL, with PROOF to validate your claims, EXACTLY what is going on here. Or is it YOU who is
MONI
Uncle Monkey Uncle Monkey 9 minutes ago
wow! huge MAGA action today. FSR

hahaha
CBRF
Natural Trader Natural Trader 10 minutes ago
it does with high PT
exwannabe exwannabe 10 minutes ago
Impossible, they have to by law. They cant simply stop discussion because NWBO "might" get refusal.
I do not claim to know how the MHRA-NICE communications work.

But I do think I understand the NICE process well enough. They are at hold waiting for the evidence submission. Ever
NWBO
Truenorth2016 Truenorth2016 10 minutes ago
Any Dip Before News IMO is a Golden Opportunity Set-up!!!
CAVR
skitahoe skitahoe 11 minutes ago
There have been many bashers here saying that NICE wouldn't even speak to the company, and it would be next year or later before they would be able to treat patients with payment from the UK healthcare system. It seems like they're very wrong and the system may be ready for patients very shortly af
NWBO
dennisdave dennisdave 12 minutes ago
so it's your belief Linda dares not to disclose negative material news Ofcourse she will but I think they will probably do that when there is no more escape route IF there is bad news to report. The 10K left them no option had they prior to that received bad news so I am pretty sure they didn't rece
NWBO
manibiotech manibiotech 12 minutes ago
I agree with your points . However there were medicines last year which got approved by MHRA but NICE decided not to get them covered by NHS same day or so. Those companies would have been in discussions with NICE before MHRA approval . So not really sure it is absolutely comforting . Looks like the
NWBO
fwb fwb 12 minutes ago
You have issues,
find a woman
Let her HELP YOU get RIGHT... if you know what I mean
PLTR
I-Glow I-Glow 12 minutes ago
I believe there is a caveat to that provision as the company also has to be Deficienct in another listing requirement.

TK, can explain it much better as well as others.

IG
MULN
ddls ddls 12 minutes ago
4/28/25, Buy: 525,000, Neutral: 4,076,000, Sell: 11,275,500

One last day buy ask slap trade to make this junk look good.
BIEL
archilles archilles 12 minutes ago
Isn’t there a newly graduated law student recently passed the bar exam lawyer who will take on this case for experience for small pro bono fees. This should be a relatively easy to identify the bad guys and the victims. What we have here are the victim shareholders, who got ripped off, versus the
ENZC

Your Recent History

NASDAQ
WHF
WhiteHorse Finance
USOTC
HLGN
Heliogen (QX)
LSE
PRUK
Am Prime Uk D
LSE
RC06
London Wall 52
BIT
P1IZC7
BNP Paribas Issuance
LSE
DIAL
Diales
BIT
UC5GTZ
Unicredit Bank
NASDAQ
LPCN
Lipocine
ASE
ALPHAE
Alpha Bank AE
USOTC
CNAF
Commercial National Fina... (QX)
USOTC
AIOSF
Atresmedia Corporation D... (PK)
Delayed Upgrade Clock
ADVFN Logo
Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads